Pharmaceutical Company
H.R. 785/S.2313, a bill for the relief of Maria Isabel Bueso Barrera, Alberto Bueso Mendoza, and Karla Maria Barrera De Bueso. Issues generally related to the Orphan Drug Tax Credit, including provisions in H,R. 2623, Camerons Law and H.R. 5376, Build Back Better Act. Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug Exclusivity Act; drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021; access to rare disease and gene therapy drugs; and FDA approvals of drugs designed to treat rare diseases, including gene therapies.

Issues pertaining to newborn screening and gene panel screening, including provisions of H.R. 482/S.350 , the Newborn Screening Saves Lives Reauthorization Act of 2021.

Policies contained in and amendments offered to S.Con.Res.5, setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; and policies contained in and amendments offered to P.L. 117-2, the American Rescue Plan Act of 2021.

Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act. Issues generally related to biopharmaceutical drugs and drug development programs, including but not limited to drug pricing proposals, Medicaid payments, and access to rare disease and gene therapy drugs. Policies contained in drug pricing proposals, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19/S.2164, Lower Costs, More Cures Act of 2021, and in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.

Policies contained in 85 FR 87000, Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. Policies contained in H.R.3684 - Infrastructure Investment and Jobs Act and H.R. 5376, Build Back Better Act.

Consideration of issues pertaining to PKU patients lost to follow up to be included in FY 2022 Labor, Health and Human Services, Education and Related Agencies funding bills.
IMM - Immigration TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CHAMBER HILL STRATEGIES
3325 N Kensington Street, Arlington, VA, 22207, US
ARIEL ALEJANDRO GONZALEZ MELISSA BARTLETT (Counsel, U.S. House of Representatives, Committee on Energy and Commerce) ARIEL ALEJANDRO GONZALEZ MELISSA BARTLETT (Counsel, U.S. House of Representatives, Committee on Energy and Commerce) MELISSA BARTLETT (Counsel, U.S. House of Representatives, Committee on Energy and Commerce) ARIEL ALEJANDRO GONZALEZ MELISSA BARTLETT (Counsel, U.S. House of Representatives, Committee on Energy and Commerce) ARIEL ALEJANDRO GONZALEZ MELISSA BARTLETT (Counsel, U.S. House of Representatives, Committee on Energy and Commerce) ARIEL ALEJANDRO GONZALEZ
Counsel, U.S. House of Representatives, Committee on Energy and Commerce Counsel, U.S. House of Representatives, Committee on Energy and Commerce Counsel, U.S. House of Representatives, Committee on Energy and Commerce Counsel, U.S. House of Representatives, Committee on Energy and Commerce Counsel, U.S. House of Representatives, Committee on Energy and Commerce